Ernexa Therapeutics ERNA SEC Filings

NASDAQ ERNA
$2.10 -0.01 (-0.47%)
As of: Oct 22, 2026 · 11:03 AM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Ernexa Therapeutics Inc. (ERNA) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001493152-26-047287Oct 15, 2026 5:25 PM
23Insider Transaction0001493152-26-043714Sep 22, 2026 8:13 PM
38-KCurrent Report0001493152-26-042963Sep 16, 2026 5:30 PM
48-KCurrent Report0001493152-26-042934Sep 16, 2026 4:50 PM
54Insider Transaction0001493152-26-041137Sep 1, 2026 1:59 AM
64Insider Transaction0001493152-26-041135Sep 1, 2026 1:56 AM
74Insider Transaction0001493152-26-041133Sep 1, 2026 1:49 AM
84Insider Transaction0001493152-26-041132Sep 1, 2026 1:48 AM
94Insider Transaction0001493152-26-041131Sep 1, 2026 1:47 AM
104Insider Transaction0001493152-26-041130Sep 1, 2026 1:46 AM
113Insider Transaction0001493152-26-040466Aug 27, 2026 11:52 PM
1210-QQuarterly & Annual Report0001493152-26-036424Aug 6, 2026 9:31 PM
138-KCurrent Report0001493152-26-031930Jul 2, 2026 8:40 PM
148-KCurrent Report0001493152-26-031920Jul 2, 2026 8:30 PM
158-KCurrent Report0001493152-26-030306Jun 26, 2026 8:30 PM
16SCHEDULE 13GBeneficial Ownership Report0001708828-26-000225May 20, 2026 8:50 PM
17SCHEDULE 13GBeneficial Ownership Report0001193125-26-227556May 15, 2026 12:54 AM
18SCHEDULE 13GBeneficial Ownership Report0001193125-26-227548May 15, 2026 12:50 AM
19SCHEDULE 13GBeneficial Ownership0001171520-26-000096May 14, 2026 5:45 PM-
20SCHEDULE 13GBeneficial Ownership0001708828-26-000185May 14, 2026 12:31 PM-
21SCHEDULE 13G/AOthers0001104659-26-060524May 13, 2026 9:49 PM-
22ARSOthers0001493152-26-022288May 11, 2026 5:17 PM
23DEFA14AOthers0001493152-26-022284May 11, 2026 5:12 PM
24DEF 14AOthers0001493152-26-022281May 11, 2026 5:09 PM
2510-QQuarterly & Annual Report0001493152-26-022276May 11, 2026 5:02 PM
268-KCurrent Report0001493152-26-021112May 4, 2026 8:10 PM
27DEF 14COthers0001493152-26-016310Apr 13, 2026 1:28 PM
28PRE 14COthers0001493152-26-014709Apr 1, 2026 9:23 PM
29EFFECTOthers9999999995-26-000994Mar 30, 2026 4:15 AM
30S-3Prospectus0001493152-26-012387Mar 24, 2026 8:59 PM
318-KCurrent Report0001493152-26-011922Mar 20, 2026 9:00 PM
32S-3Prospectus0001493152-26-010128Mar 16, 2026 10:13 PM
3310-KQuarterly & Annual Report0001493152-26-010102Mar 13, 2026 9:22 PM
348-KCurrent Report0001493152-26-008182Feb 26, 2026 9:31 PM
35SCHEDULE 13DBeneficial Ownership Report0001104659-26-016685Feb 17, 2026 2:26 AM
36SCHEDULE 13DBeneficial Ownership Report0001104659-26-016685Feb 17, 2026 2:26 AM
37SCHEDULE 13DBeneficial Ownership Report0001104659-26-016685Feb 17, 2026 2:26 AM
384Insider Transaction0001104659-26-016680Feb 17, 2026 2:14 AM
394Insider Transaction0001104659-26-016680Feb 17, 2026 2:14 AM
404Insider Transaction0001104659-26-016680Feb 17, 2026 2:14 AM
418-KCurrent Report0001493152-26-006227Feb 11, 2026 10:10 PM
42424B5Prospectus0001493152-26-005898Feb 10, 2026 1:42 PM
43EFFECTOthers9999999995-26-000458Feb 5, 2026 5:15 AM
44CERTOthers0001354457-26-000143Feb 5, 2026 8:11 PM
458-A12BOthers0001493152-26-005226Feb 5, 2026 4:33 PM
46S-1Prospectus0001493152-26-005215Feb 5, 2026 2:46 PM
47S-1Prospectus0001493152-26-004987Feb 4, 2026 2:59 AM
48S-1Prospectus0001493152-26-004809Feb 3, 2026 1:10 AM
49SCHEDULE 13GBeneficial Ownership Report0001193125-25-326739Dec 19, 2025 8:50 PM
50SCHEDULE 13GBeneficial Ownership Report0001193125-25-326739Dec 19, 2025 8:50 PM
...

Ernexa Therapeutics Inc. SEC Filings API

Pull Ernexa Therapeutics Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ERNA&formtype=10-K,10-Q&api_key=YOUR_API_KEY